JAMES OUTLAND: Open Payments
NPI 1922006295 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,154 in 67 payments from 12 companies in 2025. Trend: 2023 $1,056 · 2024 $1,255 · 2025 $1,154
Food & beverage: $1,145Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $518 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $154 |
| Janssen Biotech, Inc. | 4 | $94 |
| UCB, Inc. | 5 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $79 |
| GENZYME CORPORATION | 3 | $51 |
| Organon LLC | 4 | $38 |
| PFIZER INC. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Incyte Corporation | 1 | $24 |
Products named: SKYRIZI, RINVOQ, ILUMYA, TREMFYA, Bimzelx, DUPIXENT, Rhapsido, VTAMA.
Industry payments across KY — which companies pay providers there.
